Effects of 24R,25- and 1α,25-dihydroxyvitamin D3 on mineralizing growth plate chondrocytes

Journal of Cellular Biochemistry

Volumn 98, Issue 2, 2006, Pages 309-334

  Wu, L N Y ^a   Genge, B R ^a   Ishikawa, Y ^a   Ishikawa, T ^a   Wuthier, R E ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

1,25 dihydroxyvitamin D3; 24,25 dihydroxyvitamin D3; Alkaline phosphatase; Calcium and phosphate deposition; Growth plate chondrocytes; Lactate dehydrogenase; Proteoglycans

Indexed keywords

24,25 DIHYDROXYCOLECALCIFEROL; ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM ION; DNA; LACTATE DEHYDROGENASE; PHOSPHATE; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CALCIUM TRANSPORT; CARTILAGE CELL; CHICKEN; CONTROLLED STUDY; CULTURE MEDIUM; DNA CONTENT; ENZYME ACTIVITY; EXTRACELLULAR FLUID; EXTRACELLULAR MATRIX; GROWTH PLATE; HYPOCALCEMIA; INTESTINE ABSORPTION; MINERALIZATION; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN CONTENT; SERUM;

24,25-DIHYDROXYVITAMIN D 3; ALKALINE PHOSPHATASE; ANIMALS; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELLS, CULTURED; CHICKENS; CHONDROCYTES; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH PLATE; L-LACTATE DEHYDROGENASE; PHOSPHATES; PROTEINS; PROTEOGLYCANS; VITAMIN D;

ANIMALIA; AVES;

EID: 33646163243     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20767     Document Type: Article

References (87)

1. Adkisson HDt, Risener FS, Jr., Zarrinkar PP, Walla MD, Christie WW, Wuthier RE. 1991. Unique fatty acid composition of normal cartilage: Discovery of high levels of n-9 eicosatrienoic acid and low levels of n-6 polyunsaturated fatty acids. Faseb J 5:344-353.
2. Ames BN. 1966. Assay of inorganic phosphate, total phosphate and phosphatases. Methods Enzymol 8:115-118.
3. Anderson HC, Hsu HH, Morris DC, Fedde KN, Whyte MP. 1997. Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am J Pathol 151:1555-1561.
4. Anderson HC, Harmey D, Camacho NP, Garimella R, Sipe JB, Tague S, Bi X, Johnson K, Terkeltaub R, Millan JL. 2005. Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. Am J Pathol 166:1711-1720.
5. Bagi DM, Miller SC. 1992. Dose-related effects of 1,25-dihydroxyvitamin D3 on growth, modeling, and morphology of fetal mouse metarsals cultured in serum-free medium. J Bone Min Res 7:29-40.
6. Baginski ES, Marie SS, Clark WL, Zak B. 1973. Direct microdetermination of serum calcium. Clin Chim Acta 46:49-54.
7. Beck GR, Jr. 2003. Inorganic phosphate as a signaling molecule in osteoblast differentiation. J Cell Biochem 90:234-243.
8. Beck GR, Jr., Knecht N. 2003. Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J Biol Chem 278:41921-41929.
9. Beck GR, Jr., Moran E, Knecht N. 2003. Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. Exp Cell Res 288:288-300.
10. Bikle DDSP, Ryzen E, Haddad JG. 1985. Serum protein binding of 1,25-dihydroxyvitamin D: A re-evaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab 61:969-975.
11. Bikle DDGE, Halloran B, Kowalski MA, Ryzen E, Haddad JG. 1986. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 63:954-959.
12. Blandford NR, Sauer GR, Genge BR, Wu LN, Wuthier RE. 2003. Modeling of matrix vesicle biomineralization using large unilamellar vesicles. J Inorg Biochem 94:14-27.
13. Boiteux A, Hess B. 1981. Design of glycolysis. Philos Trans R Soc Lond B Biol Sci 293:5-22.
14. Boyan BD, Sylvia VL, Dean DD, Del Toro F, Schwartz Z. 2002. Differential regulation of growth plate chondrocytes by 1alpha,25-(OH)2D3 and 24R,25-(OH)2D3 involves cell-maturation-specific membrane-receptor-activated phospholipid metabolism. Crit Rev Oral Biol Med 13:143-154.
15. Bushinsky DA, Riera GS, Favus MJ, Coe FL. 1985a. Evidence that blood ionized calcium can regulate serum 1,25(OH)2D3 independently of parathyroid hormone and phosphorus in the rat. J Clin Invest 76:1599-1604.
16. Bushinsky DA, Riera GS, Favus MJ, Coe FL. 1985b. Response of serum 1,25(OH)2D3 to variation of ionized calcium during chronic acidosis. Am J Physiol 249:F361-F365.
17. Chambers TJ. 1988. The regulation of osteoclastic development and function. Ciba Found Symp 136:92-107.
18. Chandrasekhar S, Esterman MA, Huffman HA. 1987. Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride. Anal Biochem 161:103-108.
19. Christakos S, Barletta F, Huening M, Dhawan P, Liu Y, Porta A, Peng X. 2003. Vitamin D target proteins: Function and regulation. J Cell Biochem 88:238-244.
20. Comper WD, Williams RP. 1987. Hydrodynamics of concentrated proteoglycan solutions. J Biol Chem 262:13464-13471.
21. Conrads KA, Yi M, Simpson KA, Lucas DA, Camalier CE, Yu LR, Veenstra TD, Stephens RM, Conrads TP, Beck GR. 2005. A combined proteome and microarray investigation of inorganic phosphate-induced pre-osteoblast cells. Mol Cell Proteomics 4(9):1284-1296.
22. Davis WKM, Shibata K, Farmer GR, Cortinas E, Matthews JL, Goodman DB, 1989. The immunohistochemical localization of Superoxide dismutase activity in the avian epiphyseal growth plate. Histochem J 21:210-215.
23. Dean DD, Boyan BD, Muniz OE, Howell DS, Schwartz Z. 1996. Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner. Calcif Tissue Int 59:109-116.
24. DeLuca HF. 1988. The vitamin D story: A collaborative effort of basic science and clinical medicine. Faseb J 2:224-236.
25. DeLuca HF, Schnoes HK. 1976. Metabolism and mechanism of action of vitamin D. Annu Rev Biochem 45:631-666.
26. Evans NT, Naylor PF, Rowlinson G. 1981. Diffusion of oxygen through the mouse ear. Br J Dermatol 105:45-56.
27. Farquharson C, Whitehead CC, Rennie JS, Loveridge N. 1993. In vivo effect of 1,25-dihydroxycholecalciferol on the proliferation and differentiation of avian chondrocytes. J Bone Miner Res 8:1081-1088.
28. Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millan JL, MacGregor GR, Whyte MP. 1999. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14:2015-2026.
29. Firth JD, Ebert BL, Ratcliffe PJ. 1995. Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J Biol Chem 270:21021-21027.
30. Futami TON, Nagatsuka Y, Yosizawa Z. 1979. Comparison of carbohydrate-containing substances from non-calcified and calcified portions of bovine costal cartilage. J Biochem (Tokyo, Japan) 85:1067-1073.
31. Genge BR, Sauer GR, Wu LN, McLean FM, Wuthier RE. 1988. Correlation between loss of alkaline phosphatase activity and accumulation of calcium during matrix vesicle-mediated mineralization. J Biol Chem 263:18513-18519.
32. Gerstenfeld LC, Kelly CM, Von Deck M, Lian JB. 1990. Effect of 1,25-dihydroxyvitamin D3 on induction of chondrocyte maturation in culture: Extracellular matrix gene expression and morphology. Endocrinology 126:1599-1609.
33. Gleadle JM, Ebert BL, Ratcliffe PJ. 1995. Diphenylene iodonium inhibits the induction of erythropoietin and other mammalian genes by hypoxia. Implications for the mechanism of oxygen sensing. Eur J Biochem 234:92-99.
34. Greising DM, Schwartz Z, Posner GH, Sylvia VL, Dean DD, Boyan BD. 1997. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation. J Cell Physiol 171:357-367.
35. Haddad JG, Jr. 1979. Transport of vitamin D metabolites. Clin Orthop 142:249-261.
36. Hale LV, Kemick ML, Wuthier RE. 1986. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture. J Bone Miner Res 1:489-495.
37. Hamada K, Nagai S, Tsutsumi T, Izumi T. 1998. Ionized calcium and 1,25-dihydroxyvitamin D concentration in serum of patients with sarcoidosis. Eur Respir J. 11:1015-1020.
38. Harris F, Hoffenberg R, Black E. 1965. Calcium kinetics in vitamin D deficiency rickets. II. Intestinal handling of calcium. Metabolism 14:1112-1121.
39. Henry HL, Norman AW, Taylor AN, Hartenbower DL, Coburn JW. 1976. Biological activity of 24,25-dihydroxycholecalciferol in chicks and rats. J Nutr 106:724-734.
40. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Coding JW, Terkeltaub R, Millan JL. 2002. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 99:9445-9449.
41. Hinek A, Poole AR. 1988. The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin). J Bone Miner Res 3:421-429.
42. Hoffman ALG, Wertheimer E. 1928. Glycogen content of cartilage and its significance. Pfleugers Archiv fuer die Gesamte Physiologie des Menschen und der Tiere 220:183-193.
43. Holick MF. 1995. Defects in the synthesis and metabolism of vitamin D. Exp Clin Endocrinol Diabetes 103:219-227.
44. Holick MF. 1996. Vitamin D: Photobiology, metabolism, mechanism of action, and clinical applications. In: Favus MJ, editor. "Primer on the metabolic bone diseases and disorders of mineral metabolism." Philadelphia, PA: Lippincott-Raven Publishers, pp 74-81.
45. Holick MF, DeLuca HF. 1974. Chemistry and biological activity of vitamin D, its metabolites and analogs. Adv Steroid Biochem Pharmacol 4:111-155.
46. Horton WE, Jr., Balakir R, Precht P, Liang CT. 1991. 1,25- Dihydroxyvitamin D3 down-regulates aggrecan proteoglycan expression in immortalized rat chondrocytes through a post-transcriptional mechanism. J Biol Chem 266:24804-24808.
47. Inao S, Conrad HE. 1992. Coordinate inhibition of alkaline phosphatase and type X collagen syntheses by 1,25-dihydroxyvitamin D3 in primary cultured hypertrophic chondrocytes. Calcif Tissue Int 50:445-450.
48. Ishikawa Y, Wuthier RE. 1992. Development of an in vitro mineralization model with growth plate chondrocytes that does not require beta- glycerophosphate. Bone Miner 17:152-157.
49. Ishikawa Y, Chin JE, Hubbard HL, Wuthier RE. 1985. Utilization and formation of amino acids by chicken epiphyseal chondrocytes: Comparative studies with cultured cells and native cartilage tissue. J Cell Physiol 123:79-88.
50. Ishikawa Y, Chin JE, Schalk EM, Wuthier RE. 1986. Effect of amino acid levels on matrix vesicle formation by epiphyseal growth plate chondrocytes in primary culture. J Cell Physiol 126:399-406.
51. Ishikawa Y, Valhmu WB, Wuthier RE. 1987. Induction of alkaline phosphatase in primary cultures of epiphyseal growth plate chondrocytes by a serum-derived factor. J Cell Physiol 133:344-350.
52. Ishikawa Y, Wu LN, Valhmu WB, Wuthier RE. 1991. Fetuin and alpha-2HS glycoprotein induce alkaline phosphatase in epiphyseal growth plate chondrocytes. J Cell Physiol 149:222-234.
53. Ishikawa Y, Genge BR, Wuthier RE, Wu LN. 1998. Thyroid hormone inhibits growth and stimulates terminal differentiation of epiphyseal growth plate chondrocytes. J Bone Miner Res 13:1398-1411.
54. Kato Y, Shimazu A, Iwamoto M, Nakashima K, Koike T, Suzuki F, Nishii Y, Sato K. 1990. Role of 1,25-dihydroxycholecalciferol in growth-plate cartilage: Inhibition of terminal differentiation of chondrocytes in vitro and in vivo. Proc Natl Acad Sci USA 87:6522-6526.
55. Kuettner KE, Kimura JH. 1985. Proteoglycans: An overview. J Cell Biochem 27:327-336.
56. Lewinson D. 1989. Application of the ferrocyanide-reduced osmium method for mineralizing cartilage: Further evidence for the enhancement of intracellular glycogen and visualization of matrix components. Histochem J 21:259-270.
57. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
58. Maeda S, Dean DD, Gay I, Schwartz Z, Boyan BD. 2001. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles. J Bone Miner Res 16:1281-1290.
59. Majeska RJ, Rodan GA. 1982. The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J Biol Chem 257:3362-3365.
60. Manolagas SC, Burton DW, Deftos LJ. 1981. 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 256:7115-7117.
61. Merke J, Klaus G, Hugel U, Waldherr R, Ritz E. 1986. No 1,25-dihydroxyvitamin D3 receptors on osteoclasts of calcium-deficient chicken despite demonstrable receptors on circulating monocytes. J Clin Invest 77:312-314.
62. Nakamura T, Kurokawa T, Orimo H. 1987. Action of 24R, 25 dihydroxyvitamin D3 (24,25 (OH)2D3) on bone in vivo. In Vivo 1(5):313-317.
63. Nakamura T, Suzuki K, Hirai T, Kurokawa T, Orimo H. 1992. Increased bone volume and reduced bone turnover in vitamin D-replete rabbits by the administration of 24R,25-dihydroxyvitamin D3. Bone 13:229-236.
64. Narisawa S, Frohlander N, Millan JL. 1997. Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 208:432-446.
65. Patzschke EDA. 1967. Distribution patterns of main metabolic pathway enzymes and intermediary metabolites in cartilage. Enzymologia Biologica et Clinica 8:421-450.
66. Rago R, Mitchen J, Wilding G. 1990. DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Anal Biochem 191:31-34.
67. Rajpurohit R, Koch CJ, Tao Z, Teixeira CM, Shapiro IM. 1996. Adaptation of chondrocytes to low oxygen tension: Relationship between hypoxia and cellular metabolism. J Cell Physiol 168:424-432.
68. Reichel H, Koeffler HP, Norman AW. 1989. The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:980-991.
69. Schwartz Z, Knight G, Swain LD, Boyan BD. 1988a. Localization of vitamin DS-responsive alkaline phosphatase in cultured chondrocytes. J Biol Chem 263:6023-6026.
70. Schwartz Z, Schlader DL, Swain LD, Boyan BD. 1988b. Direct effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities. Endocrinology 123:2878-2884.
71. Schwartz Z, Soskolne WA, Atkin I, Goldstein M, Ornoy A. 1989. A direct effect of 24,25-(OH)2D3 and 1,25-(OH)2D3 on the modeling of fetal mice long bones in vitro. J Bone Miner Res 4:157-163.
72. Schwartz Z, Brooks B, Swain L, Del Toro F, Norman A, Boyan B. 1992. Production of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by growth zone and resting zone chondrocytes is dependent on cell maturation and is regulated by hormones and growth factors. Endocrinology 130:2495-2504.
73. Schwartz Z, Dean DD, Walton JK, Brooks BP, Boyan BD. 1995. Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3-responsive phenotype characteristic of growth zone chondrocytes. Endocrinology 136:402-411.
74. Sebert JL, Fournier A, Lambrey G, Moriniere P, Decourcelle PH, Makdassi R, De Fremont JF. 1982. [Does 24,25 dihydroxycholecalciferol have a physiological and pathophysiological role?]. Nephrologie 3:133-141.
75. Seo EG, Kato A, Norman AW. 1996. Evidence for a 24R,25(OH)2-vitamin D3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus. Biochem Biophys Res Commun 225:203-208.
76. Takigawa M, Enomoto M, Shirai E, Nishii Y, Suzuki F. 1988. Differential effects of 1 alpha,25-dihydroxycholecalciferol and 24R,25- dihydroxycholecalciferol on the proliferation and the differentiated phenotype of rabbit costal chondrocytes in culture. Endocrinology 122:831-839.
77. Tietz NW, Burtis CA, Duncan P, Ervin K, Petitclerc CJ, Rinker AD, Shuey D, Zygowicz ER. 1983. A reference method for measurement of alkaline phosphatase activity in human serum. Clin Chem 29:751-761.
78. Torzilli PA, Arduino JM, Gregory JD, Bansal M. 1997. Effect of proteoglycan removal on solute mobility in articular cartilage. J Biomech 30:895-902.
79. Townsend FJ, Gibson MA. 1970. A histochemical study of glycogen metabolism in developing cartilage and bone. Can J Zool 48:87-95.
80. Wasserman RH. 1964. Vitamin D and the intestinal absorption of calcium. NY State J Med 64:1329-1332.
81. Wu LN, Sauer GR, Genge BR, Wuthier RE. 1989. Induction of mineral deposition by primary cultures of chicken growth plate chondrocytes in ascorbate-containing media. Evidence of an association between matrix vesicles and collagen. J Biol Chem 264:21346-21355.
82. 2+ and Pi prior to matrix mineralization. J Cell Biochem 57:218-237.
83. Wu LN, Ishikawa Y, Genge BR, Sampath TK, Wuthier RE. 1997a. Effect of osteogenic protein-1 on the development and mineralization of primary cultures of avian growth plate chondrocytes: Modulation by retinoic acid. J Cell Biochem 67:498-513.
84. Wu LN, Ishikawa Y, Nie D, Genge BR, Wuthier RE. 1997b. Retinoic acid stimulates matrix calcification and initiates type I collagen synthesis in primary cultures of avian weight-bearing growth plate chondrocytes. J Cell Biochem 65:209-230.
85. Wuthier RE. 1969. A zonal analysis of inorganic and organic constituents of the epiphysis during endochondral calcification. Calcif Tissue Res 4:20-38.
86. Wuthier RE. 1971. Zonal analysis of electrolytes in epiphyseal cartilage and bone of normal and rachitic chickens and pigs. Calcif Tissue Res 8:24-35.
87. Wuthier RE. 1977. Electrolytes of isolated epiphyseal chondrocytes, matrix vesicles, and extracellular fluid. Calcif Tissue Res 23:125-133.